Tardive Dyskinesia
- 1 June 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 41 (6) , 623-627
- https://doi.org/10.1001/archpsyc.1984.01790170097011
Abstract
• Twenty-one nonschizophrenic and 12 schizophrenic outpatients with tardive dyskinesia (TD) were followed up for a mean of 12.0 and 8.6 months, respectively, following discontinuation of neuroleptic therapy. Of the 33 patients, only one demonstrated complete reversal of TD. Cumulative survival curves of the length of time to first improvement (reduction in movement ratings by 50% of baseline) did not differ between the two groups. The median time to first improvement was seven months. If a patient can be kept off of a neuroleptic regimen for 18 months, the estimated probability of showing a 50% reduction in movement is 87.2%. In the nonschizophrenic group, depressed mood was negatively correlated with severity of abnormal movements.Keywords
This publication has 18 references indexed in Scilit:
- A TARDIVE DYSKINESIA CLINIC IN A MENTAL HEALTH CENTERPsychiatric Services, 1981
- A systematic investigation of tardive dyskinesia in inpatientsAmerican Journal of Psychiatry, 1979
- Tardive Dyskinesia—Reversible and PersistentArchives of General Psychiatry, 1979
- Tardive dyskinesia: are first signs reversible?American Journal of Psychiatry, 1977
- Atypical tardive dyskinesiaAmerican Journal of Psychiatry, 1975
- Rapid Reversal of Tardive DyskinesiaAmerican Journal of Psychiatry, 1973
- Persistence of Neurological Symptoms Due to Neuroleptic DrugsAmerican Journal of Psychiatry, 1971
- The Significance of Brain Damage in Persistent Oral DyskinesiaThe British Journal of Psychiatry, 1970
- Persistent Oral Dyskinesia in Female Mental Hospital PatientsThe British Journal of Psychiatry, 1966
- Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapyPsychopharmacology, 1960